Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Cash from Financing Activities (2022 - 2023)

Historic Cash from Financing Activities for Therapeutics (LENZ) over the last 2 years, with Q4 2023 value amounting to -$1.9 million.

  • Therapeutics' Cash from Financing Activities fell 88319.67% to -$1.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $80.7 million, marking a year-over-year increase of 1341758.79%. This contributed to the annual value of $199.0 million for FY2024, which is 14659.48% up from last year.
  • Latest data reveals that Therapeutics reported Cash from Financing Activities of -$1.9 million as of Q4 2023, which was down 88319.67% from -$568000.0 recorded in Q3 2023.
  • In the past 5 years, Therapeutics' Cash from Financing Activities ranged from a high of $83.2 million in Q1 2023 and a low of -$1.9 million during Q4 2023